Article
Effect of topical soluble epoxide hydrolase inhibition in a preclinical diabetic wound…
bioRxiv · 2019 · William C. Reisdorf
Key facts
| Title | Effect of topical soluble epoxide hydrolase inhibition in a preclinical diabetic wound healing model |
|---|---|
| First author | William C. Reisdorf |
| Journal | bioRxiv |
| Published | Mar 13, 2019 |
| DOI | 10.1101/571984 |
| Devices mentioned | K011083, K032806, K033584, K033669, K060736, K072818, K082516, K090675, K090926, K092015, K093047, K093163 and 38 more |
| Product codes mentioned | EMX, FSM, FZX, GDZ, GEI, HAB, HRS, HWC, LXT, HRY, HSB, HSD and 32 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1